Randomized double-blinded study to commence on DigiFab® for kidney injury related to CABG surgery |
| August 05, 2019 | August 2019 Bond Updates |
|
PHILADELPHIA, Aug. 5, 2019 /PRNewswire/ -- BTG plc (LSE: BTG), the global healthcare company, today announced the start of a randomized double-blinded clinical study, initiated by researchers at the University of Maryland School of Medicine (UMSOM), that examines the role of DigiFab®... |
| View more at: https://www.prnewswire.com:443/news-releases/randomized-double-blinded-study-to-commence-on-digifab-for-kidney-injury-related-to-cabg-surgery-300896236.html |
| Related News |
|